Skip to content

3Accepted Jul 17, 7:40 PM ET

Versant Venture Capital V, L.P. 3

CRNXCrinetics Pharmaceuticals, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

7:40 PM

Jul 17, 2018

Filed

Jul 17, 2018

Documents

1

Size

22.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.